Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 853 clinical trials
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (FUTURE-II)

The FUTURE-II study is a confirmative clinical trial for Sirolimus Target Eluting Bioresorbable Vascular Scaffold (Firesorb) after the feasibility and safety of the device has been preliminary confirmed in a small-scale First-in-Man clinical trial.

angina pectoris
everolimus
ischemia
myocardial infarction
unstable angina
  • 51 views
  • 01 Mar, 2022
  • 1 location
FANTOM Post Market Clinical Trial

Post Market study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold

bypass graft
stenosis
ischemia
sirolimus
chest pain
  • 7 views
  • 05 Mar, 2022
  • 10 locations
IVUS-guided DK Crush Stenting Technique for Patients With Complex Bifurcation Lesions (DKCRUSH-VIII)

This study is designed to investigate whether IVUS-guided DK crush stenting technique compared to angiography-guided DK crush after the indexed procedure will lead to lower rates of the composite endpoint of target vessel failure (TVF) at 12 months. The individual components of TVF include cardiac death, target-vessel myocardial infarction (MI), …

revascularisation
myocardial infarction
intravascular ultrasound
angiography
infarct
  • 0 views
  • 26 Apr, 2022
  • 1 location
PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG (PROCTOR)

Multi-centre, randomised clinical trial with anticipated 17 European centres: in the Netherlands, Belgium, Germany and UK. Patients with a dysfunctional bypass graft with a clinical indication for revascularization will be randomized to either PCI of the native vessel or PCI of the dysfunctional venous bypass graft. 584 patients with a …

percutaneous coronary intervention
ischemia
angiography
dapt
coronary disease
  • 0 views
  • 27 Feb, 2022
  • 14 locations
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study

An intervention study with longitudinal follow-up of patients with coronary artery disease undergoing early cardiac rehabilitation is designed.

  • 0 views
  • 22 Jan, 2021
  • 1 location
1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Prospective, multicenter, randomized, double-blind, placebo-controlled trials.

angina pectoris
antiplatelet therapy
percutaneous coronary intervention
ticagrelor
myocardial infarction
  • 0 views
  • 18 Nov, 2021
  • 1 location
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions

This study is designed to investigate whether drug-coated balloon (DCB) compared to conventional balloon angioplasty for side branch after provisional stenting will lead to lower rates of the composite endpoint of major adverse cardiac event (MACE) at 12 months. The individual components of MACE include cardiac death, myocardial infarction (MI), …

angina pectoris
coronary angioplasty
percutaneous coronary intervention
cardiac event
ischemia
  • 0 views
  • 17 Nov, 2021
  • 1 location
Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring

The overall goal of this study is to develop a combined polygenic risk score (PRS) and metabolic risk score (MRS) and determine its impact on selecting community members for CCS. The trial component of this study will compare the use of these scores to motivate people to adhere to therapy, …

  • 0 views
  • 01 Feb, 2021
  • 1 location
Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Japan Study (FAVOR III EJ)

Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. QFR is estimated based on two angiographic projections. Studies have shown a good correlation with the present wire-based standard approach Fractional Flow Reserve (FFR) for assessment of intermediate coronary stenosis. The purpose of the …

angina pectoris
stable angina
stenosis
angiography
adenosine
  • 25 views
  • 28 Jun, 2022
  • 37 locations
HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

The study aims to evaluate the safety and efficacy of biodegradable polymer sirolimus-eluting coronary stent system (HELIOS) in patients with coronary artery disease . The primary endpoint is target lesion failure, a composite endpoint of cardiac death, target vessel related myocardial infarction and clinically-driven target lesion revascularization at 1 year …

revascularisation
biodegradable polymer
myocardial infarction
sirolimus
arterial disease
  • 11 views
  • 03 Feb, 2022
  • 1 location